Skip navigation
Home
Menu
Menu
Study
Student life
Research and innovation
Global
About us
Staff
Students
Search the site
Centre of Excellence for Long-acting Therapeutics
Menu
About us
LONGEVITY Project
Nanotherapeutics Hub
Teoreler
PKRxiv
LAPaL
Blog
Our News
Events
Contact us
News
Foresee Pharmaceuticals Receives the Third Positive Recommendation from the DSMB to Continue the Casppian Study
21 February 2025
U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review
21 February 2025
EyePoint announces positive six-month results for phase 2 VERONA clinical trial of DURAVYU™ for diabetic macular edema meeting primary and secondary endpoints
14 February 2025
Invivyd announces positive phase 1/2 clinical data for VYD2311, a monoclonal antibody to be a alternative to COVID-19 vaccination for the broad population
07 February 2025
This new drug delivery method could offer long-lasting relief for eye diseases
07 February 2025
European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria + Rekambys for HIV treatment in adolescents
31 January 2025
Narrating medicine: Experiences of HIV treatment and prevention
31 January 2025
Health Canada approves (Pr)ABILIFY ASIMTUFII® (aripiprazole), the first, once-every-two-months, long-acting injectable treatment for schizophrenia
24 January 2025
UNAIDS calls on leaders at Davos to commit to rapid global access to revolutionary new long-acting HIV medicines
24 January 2025
Novo Holdings invests in $200M Series A for Windward Bio launch to advance long-acting treatments for asthma and COPD
17 January 2025
News
Foresee Pharmaceuticals Receives the Third Positive Recommendation from the DSMB to Continue the Casppian Study
21 February 2025
U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review
21 February 2025
EyePoint announces positive six-month results for phase 2 VERONA clinical trial of DURAVYU™ for diabetic macular edema meeting primary and secondary endpoints
14 February 2025
Invivyd announces positive phase 1/2 clinical data for VYD2311, a monoclonal antibody to be a alternative to COVID-19 vaccination for the broad population
07 February 2025
This new drug delivery method could offer long-lasting relief for eye diseases
07 February 2025
European Commission authorises ViiV Healthcare’s long-acting injectable Vocabria + Rekambys for HIV treatment in adolescents
31 January 2025
Narrating medicine: Experiences of HIV treatment and prevention
31 January 2025
Older Stories
.jpg)
.jpg)
